Global Health Share Price: 16.8% CAGR in 3 Years as the Medanta Hospital Operator Compares With Apollo Hospitals, Fortis Healthcare and Rainbow Children’s Medicare
- November 19, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Global Health Share Price: 16.8% CAGR in 3 Years as the Medanta Hospital Operator Compares With Apollo Hospitals, Fortis Healthcare and Rainbow Children’s Medicare
Global Health previous close Rs 1,436.60. 3-year CAGR 16.8%. Up 1.6x since 17 Nov 2023. ROE 14.30%. Market cap Rs 38,579 crore.
Quick Answer
The Global Health share price closed at Rs 1,436.60 on 18 November 2026, a compounded annual return of 16.8% over three years. That compares with Apollo Hospitals at 17.2%, Fortis Healthcare at 30.6% and Rainbow Children’s Medicare at 5.1%. The company has a market cap of Rs 38,579 crore and a P/E of 62.93 against an industry P/E of 63.96.
The Global Health share price closed at Rs 1,436.60 on 18 November 2026 and has compounded at 16.8% a year over three years. Global Health, based in Gurugram, runs the Medanta hospitals, which focus on complex care such as heart, liver and cancer treatment.
This article places that return beside Apollo Hospitals, Fortis Healthcare and Rainbow Children’s Medicare. We calculate the three-year CAGR for all four and set the results next to market cap, valuation, return on equity and debt, using prices adjusted for corporate actions.
Click Here – Get Free Investment Predictions
How Much Has the Global Health Share Price Returned in 3 Years?
The Global Health stock closed at Rs 902.50 on 17 November 2023 and at Rs 1,436.60 on 18 November 2026. Rs 1 lakh invested three years ago would have grown to about Rs 1.59 lakh, which is a CAGR of 16.8%. This is a price return and leaves out dividends.
CAGR condenses a bumpy three-year ride into one yearly number, which is why it is the fairest way to compare companies of different sizes. A stock such as Global Health can look spectacular on a chart and still have earned a modest yearly return, so the compounded figure keeps the comparison honest.
A tertiary care hospital earns more from each patient than a general hospital, so the price depends on case mix, bed additions and doctor retention. The Global Health share price gives investors a direct way to follow the Medanta brand.
Global Health vs Apollo Hospitals, Fortis Healthcare and Rainbow Children’s Medicare: 3-Year CAGR Compared
The table ranks the companies by three-year CAGR. Prices on 17 November 2023 are adjusted for splits and bonuses, and the latest figures are the previous close on 18 November 2026.
| Company | Close on 17 Nov 2023 | Previous close (18 Nov 2026) | Price multiple | 3-year CAGR |
|---|---|---|---|---|
| Fortis Healthcare | Rs 356.30 | Rs 793.55 | 2.2x | 30.6% |
| Apollo Hospitals | Rs 5,478.95 | Rs 8,821.00 | 1.6x | 17.2% |
| Global Health (Medanta) | Rs 902.50 | Rs 1,436.60 | 1.6x | 16.8% |
| Rainbow Children’s Medicare | Rs 1,084.50 | Rs 1,258.00 | 1.2x | 5.1% |
The Global Health stock ranks third of the four at 16.8%. It sits ahead of Rainbow Children’s Medicare (5.1%). The companies ahead are Fortis Healthcare (30.6%) and Apollo Hospitals (17.2%). By market cap the company ranks third of the four at Rs 38,579 crore. Apollo Hospitals is the largest of the four by market cap.
Look at the Global Health share price alongside the peers as a snapshot of the last three years. It describes what happened, and valuation and earnings will decide what happens next.
Valuation and Quality Compared
| Company | Market cap | P/E | Industry P/E | ROE | Debt to equity |
|---|---|---|---|---|---|
| Apollo Hospitals | Rs 1,26,689 crore | 54.20 | 63.96 | 21.14% | 0.77 |
| Fortis Healthcare | Rs 60,170 crore | 56.65 | 63.96 | 9.91% | 0.30 |
| Global Health (Medanta) | Rs 38,579 crore | 62.93 | 63.96 | 14.30% | 0.31 |
| Rainbow Children’s Medicare | Rs 12,773 crore | 42.79 | 63.96 | 17.05% | 0.56 |
By market cap, Apollo Hospitals is the largest of the group at Rs 1,26,689 crore, while the Global Health stock stands at Rs 38,579 crore, about 30% of that size. On earnings, Global Health shares trade at a P/E of 62.93 against an industry P/E of 63.96, a discount of about 2% to the sector, which leaves room if earnings keep growing. Peer multiples are Apollo Hospitals at 54.20, Fortis Healthcare at 56.65 and Rainbow Children’s Medicare at 42.79.
Return on equity is 14.30% for the Global Health stock, which ranks third among the four, and debt to equity stands at 0.31. Trailing EPS is Rs 22.80. Global Health trades at a P/E of 62.93 against an industry P/E of 63.96. Its ROE of 14.30% and price to book of 8.92 complete the valuation picture.
What Is Driving the Global Health Stock?
Medanta earns revenue from inpatient care, outpatient consultations and complex procedures. A larger share of high value surgeries lifts revenue per bed, while new beds and new hospitals lift total capacity.
The company earns an ROE of 14.30% and carries a debt to equity of 0.31, which is the second lowest in the group. Its P/E of 62.93 sits close to the industry P/E of 63.96.
Investors who follow the Global Health share price usually track occupancy, revenue per occupied bed, new hospital launches and the mix of international and domestic patients.
How the Established Players Stack Up
Apollo Hospitals is a Chennai-based hospital chain with a large pharmacy and digital health arm. It compounded at 17.2% a year, on a market cap of Rs 1,26,689 crore and an ROE of 21.14%.
Fortis Healthcare is a Gurugram-based hospital chain with hospitals in many Indian cities and a diagnostics business. It compounded at 30.6% a year, on a market cap of Rs 60,170 crore and an ROE of 9.91%.
Rainbow Children’s Medicare is a Hyderabad-based chain of hospitals focused on children and women’s care. It compounded at 5.1% a year, on a market cap of Rs 12,773 crore and an ROE of 17.05%.
What Should Investors Track Next?
Three things are worth watching on the Global Health share price. First, occupancy and revenue per bed in the next quarterly result. Second, the pace of new bed additions. Third, operating margin as the case mix shifts.
At a P/E of 62.93 the stock trades a little below the industry P/E of 63.96, so valuation sits close to the sector. Hospital costs can move margins, so follow each result closely.
Check the Univest Screener for live fundamentals of hospital stocks
How to Compare Hospital Stocks Yourself
You can repeat this exercise for any pair of stocks, including the Global Health stock against its peers. Note the adjusted closing price on the base date, take the latest close, divide one by the other, raise the result to the power of one third and subtract one. Then place the CAGR next to market cap, P/E against the industry P/E, ROE and debt to equity. Benchmark the result against the Nifty 50 as well, so you know whether the stock beat the broader market.
A stock that scores well on growth but weakly on quality, or the reverse, deserves closer study before it enters a portfolio. When tracking the Global Health share price, the same four checks give a more complete picture than price alone.
Download the Univest iOS App or Univest Android App to track the Global Health share price and compare hospital stocks live.
The Medanta Operator Beside Three Hospital Chains
The Global Health share price compounded at 16.8% a year over three years, against 30.6% for Fortis, 17.2% for Apollo Hospitals and 5.1% for Rainbow. Its market cap is Rs 38,579 crore.
Fortis Healthcare brings the fastest return, Apollo Hospitals brings the highest ROE and Rainbow Children’s Medicare brings the lowest P/E. Global Health offers a focus on complex care, which the other three cover alongside broader services.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the Global Health share price today?
Ans. Global Health (Medanta) closed at Rs 1,436.60 on 18 November 2026, according to NSE data. It has a market cap of Rs 38,579 crore and a P/E of 62.93. Check live quotes before acting, as prices change every trading day.
What is the 3-year CAGR of the Global Health stock?
Ans. Global Health (Medanta) delivered a price CAGR of 16.8% over three years, moving from Rs 902.50 on 17 November 2023 to Rs 1,436.60 on 18 November 2026. The figure excludes dividends and uses adjusted closing prices.
Is Global Health better than Apollo Hospitals?
Ans. Apollo Hospitals delivered the higher three-year CAGR at 17.2% against 16.8% for Global Health. Apollo Hospitals has the larger market cap at Rs 1,26,689 crore against Rs 38,579 crore for Global Health. Apollo Hospitals earns the higher ROE at 21.14% against 14.30%. Apollo Hospitals trades at the lower P/E of 54.20 against 62.93. The better choice depends on whether you weigh recent return, size, profitability or valuation most.
What does Global Health (Medanta) do?
Ans. Global Health Limited is a Gurugram-based healthcare company that operates the Medanta group of multi-speciality hospitals in India.
Is the Global Health stock debt free?
Ans. The debt to equity ratio of the Global Health stock is 0.31 and its return on equity is 14.30%. Always check the latest balance sheet for current figures, as debt levels change with expansion plans.
Is Global Health expensive compared with the industry?
Ans. Global Health trades at a P/E of 62.93 against an industry P/E of 63.96. A higher multiple reflects expectations of faster growth, which the company must deliver through earnings.
Which hospital stock gave the highest return in 3 years?
Ans. Among the companies compared here, Fortis Healthcare delivered the highest three-year CAGR at 30.6%, followed by Apollo Hospitals at 17.2%. Past returns do not guarantee future performance.
How do I calculate CAGR for a stock?
Ans. Divide the latest price by the starting price, raise the result to the power of one divided by the number of years, and subtract one. Multiply by 100 for a percentage. Use split and bonus adjusted prices for accurate results.